... of the protease [23–25].We here report crystallographic studies of C-terminallyduplicated C2 -symmetric and asymmetric inhibitors in complex with the HIV-1 protease. These compounds,including ... approved six inhibitors: ampre-navir, indinavir, lopinavir, nelfinavir, ritonavir and saqui-navir [10]. The side effects of these inhibitors and the clinicalemergence of resistant mutants in HIV-1 ... identical P1/P1¢,P2/P2¢ and P3/P3¢ groups. The asymmetric positioning of the inhibitor in the protease substrate-binding site, especially the interactions betweenthe inhibitor and the flaps, may be...